Why 454 million people are waiting for a device already in their pocket
The Smartphone Revolution in Respiratory Care Has Arrived, And It Changes Everything
AI in Medicine: Building the Mindset for a New Era of Healthcare
Insights from Bipin Patel, CEO & Founder
Harnessing population health strategies to transform ILD outcomes
Interstitial lung diseases (ILDs) represent a diverse group of over 200 chronic respiratory conditions characterised by varying degrees of inflammation and fibrosis of the lung tissue.
Population health in respiratory care: From data to actionable insights
In an era where healthcare systems face mounting pressures from chronic disease burdens, population health has emerged as a strategic framework to improve outcomes across communities rather than focusing solely on individual patients.
The 15-year warning: Why we need to measure lung decline in traffic jams, not clinic waiting rooms
Insights from Bipin Patel, CEO & Founder
Reactive to predictive: potential of lung age for chronic disease management
Insights from Bipin Patel, CEO & Founder
Reimagining COPD care for 450 million people: A global mission at scale
A global epidemic
Beyond the inhaler: Why the future of COPD care is digital, continuous, and predictive
Inhalers: life-saving, but not enough
The smartphone revolution in lung health: Foundations for the future
Spirometry: A century-old tool in need of reinvention
The invisible infrastructure of innovation: Why Data Governance is foundational to the future of healthcare
Co-authored by Sebastian Sbirna, Novo Nordisk
Transforming patient care and provider efficiency
Co-authored Cassie McGrath, Morning Brew
Clinical insights: Respiratory care digital innovation opportunities
Co-authored by Dr Bipin Patel, CEO, electronRx, Cambridge, UK and Dr Hiromichi Yamaguchi, Yamaguchi Respiratory Clinic and Dermatology, Tokyo, Japan.
Preventing patient hospitalisation through better stratification and timely intervention
In the realm of healthcare, patient hospitalisation can often be avoided through timely intervention and appropriate medication management.
Understanding Motor Neurone Disease
Motor neurone disease (MND) is a rare but progressive neurological disorder characterised by the degeneration of motor neurones. Motor neurons are found in the brain and spinal cord and play a key role in muscle movement.
The ILD patient journey and what to expect
Navigating the journey of interstitial lung disease (ILD) can be overwhelming, filled with uncertainties, misdiagnoses, and emotional challenges. From the first signs of symptoms to receiving an accurate diagnosis and starting treatment, ILD patients often face a long and complex path.
Overcoming challenges in Pulmonary Hypertension
Pulmonary hypertension (PH) is a rare, progressive, debilitating condition characterised by elevated pulmonary artery pressure [1].
Exploring treatment options for ILD
Interstitial lung disease (ILD) refers to a group of lung disorders that cause inflammation and scarring of lung tissue, leading to progressive breathing difficulties. While there is currently no cure for ILD, treatment focuses on controlling symptoms, slowing disease progression, and improving quality of life. If left untreated, ILD can lead to serious complications and early mortality…
Unlocking the £100 billion opportunity: How continuous respiratory monitoring is transforming pharma economics
Co-authoured by Dr Steve Arlington, previously PWC, IBM and President of Pistoia Alliance
The role of AI and omnichannel strategies in healthcare marketing
Co-authored by Jose Maria (Chema) Guido Avila, Sanofi
Living with Pulmonary Arterial Hypertension: Early Diagnosis, Patient Advocacy, and the Role of Technology
Co-authored by Maleen Fischer, PHA Europe
Breathing easier: tackling Alzheimer's through respiratory insights
At electronRx, we are constantly looking for ways we can leverage cutting-edge technology to redefine healthcare. We are excited about the potential of our work in pulmonary function and its connection to neurodegenerative diseases like Alzheimer's.